Vesicular monoamine transporter 2: Role as a novel target for drug development

Cited by (131)

Items 101–131 of 131

1. LC–MS/MS Characterization of Forced Degradation Products of Tetrabenazine
   2016 · Chemical Sciences Journal
2. A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation
   Miki Ishida, Ryuya Ichikawa, Katsuya Ohbuchi, Hiroaki Oizumi, Yuki Miyamoto, Junji Yamauchi · 2025 · Scientific Reports
3. SYSTEMATIC REVIEW ON PHYTOCHEMICAL AND PHARMACOLOGICAL PROFILE OF LOBELIA NICOTIANAEFOLIA ROTH E & S
   Abrar M Tamboli, Imran Khan, Ketan Bhutkar, Rukhsana A. Rub · 2011
4. THE EFFECTS OF LOBELINE ON METHAMPHETAMINE-INDUCED CONDITIONED PLACE PREFERENCE AND DOPAMINERGIC ALTERATIONS IN THE NUCLEUS ACCUMBENS SHELL
   Nichole M. Neugebauer‎ · 2008 · UKnowledge (University of Kentucky)
5. Diseases of Protein Folding: Huntington’s Disease and Amyotrophic Lateral Sclerosis
   Barbara J. Bailus, Lisa Ellerby · 2015 · Elsevier eBooks
6. Roles of forced nicotine exposure and Comt gene disruption in the development of addiction-related behavioural and neurochemical changes in mice
   Anne Tammimäki · 2008 · Työväentutkimus Vuosikirja
7. Synthesis, Pharmacological Characterization and QSAR Modelling of 4-Phenylpiperidines and 4-Phenylpiperazines Effects on the dopaminergic neurotransmission in vivo
   Fredrik Pettersson · 2012 · Gothenburg University Publications Electronic Archive (Gothenburg University)
8. EFFECTS OF HIV-1 TAT PROTEIN ON STRUCTURE, FUNCTION AND TRAFFICKING OF THE DOPAMINE TRANSPORTER
   Narasimha M. Midde · 2014 · Scholar Commons (University of South Carolina)
9. Huntington’s Disease: An Update
   Amandeep Kaur · 2014 · Pharmatutor
10. PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES
    Yolanda S. Williams · 2011 · UKnowledge (University of Kentucky)
11. LOBELANE ANALOGS WITH VARIOUS METHYLENE LINKER LENGTHS AND ACYCLIC LOBELANE ANALOGS AS POTENTIAL PHARMACOTHERAPIES TO TREAT METHAMPHETAMINE ABUSE
    Zheng Cao · 2014 · UKnowledge (University of Kentucky)
12. Dynamic Modulation of In Vivo Serotonin Signaling
    Elyse C. Dankoski · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
13. METABOLIC CHANGES INDUCED BY BUSHENHUOXUE GRANULES ON STRIATUM AND SUBSTANTIA NIGRA IN A RAT MODEL OF PARKINSON’S DISEASE
    Yunxia Guo, Junxiu Zhang, Shaodan Li, Yin Zhang, Yi Liu, Minghui Yang · 2017 · African Journal of Traditional Complementary and Alternative Medicines
14. Minireview of Stereoselective Brain Imaging
    Donald Frederick Smith, Steen Jakobsen · 2014 · Archives of Current Research International
15. Norepinephrine
    Marla Sanzone · 2010 · Springer eBooks
16. Norepinephrine
    Marla Sanzone · 2018 · Springer eBooks
17. A role for LRRK2 and Neuroinflammatory Processes in Multi-Hit Toxicant Models of Parkinson’s Disease
    Chris Rudyk · 2018
18. Norepinephrine
    Marla Sanzone · 2017 · Springer eBooks
19. The behavioural, corticoid and hippocampal effects of low-dose paraquat exposure in middle-and-advanced-aged mice : potential implications for prodromal Parkinson's disease
    Chris Rudyk · 2012
20. Diseases of Protein Folding: Huntington's Disease and Amyotrophic Lateral Sclerosis
    Barbara J. Bailus, Lisa Ellerby · 2016 · Elsevier eBooks
21. Immunobiology and Immunotherapies in Huntington's Disease
    Arttatrana Pal, Golden Kumari, Sonu Kumar · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
22. Tyrosine Hydroxylase Deficiency Impairs TH Axonal Transport, Brain Function, and Neuronal Plasticity
    Tie-Jun Sten Shi, Kunwar Jung‐KC, Gong-Wei Lyu, Han Liang, Ming Ying, Beat Thöny, Aurora Martı́nez · 2026 · Journal of Inherited Metabolic Disease
23. The role of the serum response factor in the pathogenesis of Huntington's disease
    Ali Awada · 2021 · theses.fr (ABES)
24. Intranasal dopamine: Anatomical pathways, biological mechanisms and neuromodulatory potential
    Owen Yuan-Hsin Chao, Susanne Nikolaus, Claudia Mattern, Lih‐Chu Chiou, Joseph P. Huston · 2026 · Neuroscience & Biobehavioral Reviews
25. BindingDB Entry 50038959: Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2).
    BindingDB · 2012 · UC San Diego
26. BindingDB Entry 50006062: Exploring the effect of
    BindingDB · 2020 · UC San Diego
27. BindingDB Entry 50002133: Fluoroethoxy-1,4-diphenethylpiperidine and piperazine derivatives: Potent and selective inhibitors of [
    BindingDB · 2020 · UC San Diego
28. BindingDB Entry 50039078: Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.
    BindingDB · 2012 · UC San Diego
29. BindingDB Entry 50033393: Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
    BindingDB · 2011 · UC San Diego
30. BindingDB Entry 50027535: Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2.
    BindingDB · 2010 · UC San Diego
31. Design, synthesis, and pharmacological evaluation of three series of lobelane analogs as inhibitors of the vesicular monoamine transporter (VMAT2)
    John P. Culver · 2015 · UKnowledge (University of Kentucky)